x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 3, 2016 5:20 EST

LuminaCare Solutions is a predictive analytics product that reduces the time to selecting the correct treatment for patients with serious bacterial infections

iCrowdNewswire - Aug 3, 2016

Logo

LuminaCare Solutions, Inc.

LuminaCare Solutions is a predictive analytics product that reduces the time to selecting the correct treatment for patients with serious bacterial infections.

 

Luminacare 20  20ipad 20app 20

Company Summary

 

LuminaCare, is a Boston based startup that will provide cloud-based predictive analytics to healthcare providers both in the US and abroad. Our SaaS determines the right drug, dose and treatment duration, and will reduce the time taken to treat patients with serious bacterial infections. We are initially targeting infectious disease management, for respiratory infections. We subsequently plan to use this approach to scale in other indications.

 

Team

  • David s 20head 20shot
    Co-Founder & CEO

    15 yrs in pharmaceutical industry working at Pfizer, Vertex Pharmaceuticals, AstraZeneca. Experiencing leading teams and supporting antibacterial projects and other therapeutic areas. Expertise in pharmacokinetics and drug metabolism. PhD in Medicinal Chemistry from University of Michigan with doctoral research studying novel antibacterial targets. BSE in Aerospace Engineering from University of Michigan.

     

  • Stephen s 20head 20shot
    Co-Founder & COO

    Stephen is a entrepreneur who is experienced in fundraising, complex negotiations, and building strategic alliances. Prior to co-founding LuminaCare Solutions, Stephen was a business development executive and strategic market researcher for a predominant U.K. contract research organization. He holds a B.S. in Biology from the University of Massachusetts, Amherst.

     

  • D7bfe8b4 8808 4cbe 8013 1e84132aeee1
    Co-Founder & CTO

    As CTO of LuminaCare Solutions, Dr. Bharadwaj is responsible for implementing the Company’s strategic vision, via its technology platform and further driving its technology focus. With almost 2 decades of experience across industries spanning pharmaceutical R&D, data science and crowdsourcing, Dr. Bharadwaj has held leadership positions at Daylight Chemical Information Systems and Vertex Pharmaceuticals.

Contact Information:

Dr. David Howe

View Related News >
support